Medivation (MDVN) Submits NDA for Enzalutamide to U.S. FDA
Go back to Medivation (MDVN) Submits NDA for Enzalutamide to U.S. FDAMedivation, Inc. (NASDAQ: MDVN) | Delayed: 81.44 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $81.44 | 52 Week High | $81.48 | |||
Open | $3852.47 | 52 Week Low | $26.41 | |||
Day High | $81.44 | P/E | N/A | |||
Day Low | $81.44 | EPS | $-1.03 | |||
Volume | 13,593 |